Affiliation:
1. Institute of Applied Health Research University of Birmingham Birmingham UK
2. Birmingham Medical School University of Birmingham Birmingham UK
3. Institute for Head and Neck Studies and Education University of Birmingham Birmingham UK
Abstract
AbstractBackgroundThe traditional cancer follow‐up (FU) model for cancer survivors is by scheduled clinic appointments; however, this is not tailored to patient needs and is becoming unsustainable. Patient‐initiated follow‐up (PIFU) may be a more effective and flexible alternative. This systematic review aims to analyse all existing evidence from randomised controlled trials (RCTs) on the effectiveness of PIFU compared with other FU models that include routinely scheduled appointments in adults who have been treated with curative intent for any type of cancer.MethodsStandard systematic review methodology aimed at limiting bias was used for study identification, selection and data extraction. MEDLINE, Embase, CINAHL, the Cochrane Database of Systematic Reviews and Epistemonikos were searched for systematic reviews to March 2022, and Cochrane CENTRAL was searched for RCTs from 2018 (April 2023). Ongoing trial registers were searched (WHO ICTRP, ClinicalTrials.gov, April 2023). Eligible studies were randomised controlled trials comparing PIFU with an alternative FU model in adult cancer survivors. Risk of bias assessment was via the Cochrane risk of bias tool‐2. Meta‐analysis was precluded by clinical heterogeneity and results were reported narratively.ResultsTen RCTs were included (six breast, two colorectal, one endometrial cancer and one melanoma, total n = 1754); all studies had risk of bias concerns, particularly relating to how missing data were handled, and populations were unlikely to be representative. Limited findings in breast cancer suggested that type of FU does not affect recurrence detection or patient‐related outcomes, while PIFU may reduce the number of clinic visits. Adding patient‐led surveillance to routine FU may increase melanoma detection. Evidence for other types of cancer is too limited to draw firm conclusions.ConclusionsPIFU may be a viable FU model in breast cancer, but further research is needed for other types of cancer and on long‐term outcomes. A protocol was registered with PROSPERO (CRD42020181424).
Funder
National Institute for Health and Care Research
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference48 articles.
1. American Cancer Society.Cancer survivorship.2023. Accessed July 26 2023;https://canceratlas.cancer.org/the‐burden/cancer‐survivorship/
2. Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors;Hoeg BL;Cochrane Database Syst Rev,2019
3. Patient‐initiated appointment systems for adults with chronic conditions in secondary care;Whear R;Cochrane Database Syst Rev,2020
4. Exploring health care professionals views on alternative approaches to cancer follow-up and barriers and facilitators to implementation of a recovery package
5. Efficacy of patient-initiated follow-up clinics in secondary care: a systematic review